SI0705542T1 - Adolescent dietary composition - Google Patents

Adolescent dietary composition

Info

Publication number: SI0705542T1
Authority: SI; Slovenia
Prior art keywords: composition; caloric content; component; adolescent; total caloric
Prior art date: 1994-09-21

Application number

SI9530040T

Other languages

English (en)

Slovenian (sl)

Inventor

Carol J. Lowry

Mary K. Schmidl

Original Assignee

Novartis Nutrition Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-21

Filing date

1995-09-19

Publication date

1998-04-30

1995-09-19 Application filed by Novartis Nutrition Ag filed Critical Novartis Nutrition Ag

1998-04-30 Publication of SI0705542T1 publication Critical patent/SI0705542T1/xx

Links

235000007882 dietary composition Nutrition 0.000 title abstract 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 2
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 2
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 2
229940024606 amino acid Drugs 0.000 abstract 2
235000001014 amino acid Nutrition 0.000 abstract 2
150000001413 amino acids Chemical class 0.000 abstract 2
CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 abstract 1
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 1
239000004471 Glycine Substances 0.000 abstract 1
QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 1
CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 abstract 1
FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
229930064664 L-arginine Natural products 0.000 abstract 1
235000014852 L-arginine Nutrition 0.000 abstract 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 abstract 1
235000019393 L-cystine Nutrition 0.000 abstract 1
239000004158 L-cystine Substances 0.000 abstract 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
229930182816 L-glutamine Natural products 0.000 abstract 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
229930182844 L-isoleucine Natural products 0.000 abstract 1
239000004395 L-leucine Substances 0.000 abstract 1
235000019454 L-leucine Nutrition 0.000 abstract 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
229930195722 L-methionine Natural products 0.000 abstract 1
229930182821 L-proline Natural products 0.000 abstract 1
239000004473 Threonine Substances 0.000 abstract 1
229960003767 alanine Drugs 0.000 abstract 1
229960005261 aspartic acid Drugs 0.000 abstract 1
150000001720 carbohydrates Chemical class 0.000 abstract 1
229960003067 cystine Drugs 0.000 abstract 1
229960002989 glutamic acid Drugs 0.000 abstract 1
229960002885 histidine Drugs 0.000 abstract 1
229960000310 isoleucine Drugs 0.000 abstract 1
229960003136 leucine Drugs 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
229960004452 methionine Drugs 0.000 abstract 1
229960002429 proline Drugs 0.000 abstract 1
229960001153 serine Drugs 0.000 abstract 1
IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 abstract 1
WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 abstract 1
229960002898 threonine Drugs 0.000 abstract 1
229960004441 tyrosine Drugs 0.000 abstract 1
229960004295 valine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Pediatric Medicine (AREA)
Oil, Petroleum & Natural Gas (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

SI9530040T 1994-09-21 1995-09-19 Adolescent dietary composition SI0705542T1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/309,815 US5719133A (en)	1994-09-21	1994-09-21	Adolescent dietary composition
EP95810580A EP0705542B1 (de)	1994-09-21	1995-09-19	Diätetische Zusammensetzung für Jugendliche

Publications (1)

Publication Number	Publication Date
SI0705542T1 true SI0705542T1 (en)	1998-04-30

Family

ID=23199780

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI9530040T SI0705542T1 (en)	1994-09-21	1995-09-19	Adolescent dietary composition

Country Status (10)

Country	Link
US (2)	US5719133A (de)
EP (1)	EP0705542B1 (de)
AT (1)	ATE161397T1 (de)
CA (1)	CA2158635C (de)
DE (1)	DE69501306T2 (de)
ES (1)	ES2111384T3 (de)
GR (1)	GR3026072T3 (de)
HK (1)	HK1005768A1 (de)
SI (1)	SI0705542T1 (de)
TW (1)	TW410160B (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7455996A (en)	1995-10-27	1997-05-15	Procter & Gamble Company, The	Color stable iron, zinc and vitamin fortified dry drink mixes
GB2312621B (en) *	1996-05-02	1998-03-11	Pharma Nord Uk Limited	Anti-oxidant medicament
GB9701674D0 (en) *	1997-01-28	1997-03-19	Novartis Nutrition Ag	Use of organic compounds
GB2323030A (en) *	1997-03-12	1998-09-16	Essential Nutrition Ltd	Dietary supplements for immunocompromised patients
WO1998047497A2 (en) *	1997-04-23	1998-10-29	Fleming & Company, Pharmaceuticals	Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections
US5849335A (en) *	1997-06-02	1998-12-15	Nestec S.A.	Composition and method for providing glutamine
EP1123013A1 (de) *	1997-06-02	2001-08-16	Société des Produits Nestlé S.A.	Produkt und verfahren zur versehung von glutamine
DE69823739T2 (de) *	1997-06-05	2005-04-28	Novartis Nutrition Ag	Glycin zur Vorbeugung oder Behandlung von Transplantatabstossungen
US5922766A (en) *	1997-07-02	1999-07-13	Acosta; Phyllis J. B.	Palatable elemental medical food
US6051270A (en) *	1997-11-05	2000-04-18	Galagen, Inc.	Liquid amino acid nutritional composition
GB9725061D0 (en) *	1997-11-27	1998-01-28	Tagg Npd Limited	Revitalisation formulation
AU2217399A (en) *	1998-01-07	1999-07-26	Mark E. Jarmel	Promoting mobilization and catabolism of lipids
EP1049386A2 (de) *	1998-01-22	2000-11-08	Abbott Laboratories	Verfahren zur verbesserung der stabilität von vitamin d in einem hydrolsierte protein enthaltendem nährprodukt und das so hersteltes produkt
BR9909234A (pt)	1998-03-31	2000-11-28	Produites Nestle S A Soc D	Método para fornecimento de glutamina
US6288116B1 (en) *	1998-05-13	2001-09-11	Novartis Nutrition Ag	Method of administration of a nutritional product to a person having renal failure
EP1023843B1 (de) *	1999-01-29	2005-06-22	Sportmedizin Team Vertriebs GmbH	Zusammensetzung zur Leistungsförderung bei sportlicher Tätigkeit, ihre Herstellung und Verwendung als diätetisches Lebensmittel
DK1048226T3 (da) *	1999-04-29	2005-10-03	Nestle Sa	Sammensætning til spædbörnsernæring indeholdende proteiner fra söd valle
US6777391B1 (en)	1999-04-29	2004-08-17	Nestec S.A.	Composition for an infant formula having a low threonine content
EP1062879B1 (de) *	1999-06-26	2003-08-27	B. Braun Melsungen Ag	Wässrige Lösung für parenterale Nahrung
GB0009056D0 (en) *	2000-04-12	2000-05-31	Nestle Sa	Composition comprising free amino acids
GB0016452D0 (en) *	2000-07-04	2000-08-23	Kilgowan Limited	Vitamin K and essential fatty acids
BR0004436A (pt) *	2000-08-25	2002-04-02	Univ Minas Gerais	Complemento dietético de aminoácidos, processo para tratamento e prevenção de doenças e processo de administração de um complemento dietético de aminoácidos
ATE320831T1 (de) *	2000-10-06	2006-04-15	Dmg Italia Srl	Immunotrophische preparation zur behandlung von tonsilläre hypertrophie
US6552074B2 (en) *	2000-11-16	2003-04-22	Fukumi Morishige	Arginine/ascorbic acid mixed powder as an oral supplement
DE10057290B4 (de) *	2000-11-17	2004-01-08	Fresenius Kabi Deutschland Gmbh	Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
US6511696B2 (en) *	2000-12-13	2003-01-28	Novartis Nutrition Ag	Infant formula with free amino acids and nucleotides
US20020099037A1 (en) *	2001-01-19	2002-07-25	Akpharma, Inc.	Method for alleviating syndromes and conditions of discomfort of the mammalian intestinal and genito-urinary tracts
DE20101225U1 (de) *	2001-01-24	2001-06-13	Sportmedizin Team Vertriebs Gmbh, Berneck	Präparat für hohe körperliche Beanspruchung
EP1372641A4 (de)	2001-03-05	2004-08-25	Stephen P Ernest	Enterale formulierung
US20030105104A1 (en) *	2001-11-27	2003-06-05	Burzynski Stanislaw R.	Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
EP1466602A4 (de) *	2001-12-25	2006-03-01	Ajinomoto Kk	Organfibroseinhibitoren
US6841173B2 (en) *	2002-03-26	2005-01-11	Peter L. Reynolds	Compositions and methods directed towards sore muscles and joints
US6562378B1 (en)	2002-08-16	2003-05-13	Tsar Health Private Ltd.	Nutritional supplement for adolescents
US6565891B1 (en)	2002-08-23	2003-05-20	Tsar Health Private Ltd.	Nutritional supplement for children
US6592908B1 (en) *	2002-09-23	2003-07-15	Albert Crum	Nutritional or therapeutic compositions
AU2003274800A1 (en) *	2002-10-31	2004-05-25	Lae-Ok Park	Anticancer or antiviral composition
CN100448453C (zh) *	2003-05-22	2009-01-07	努特里奇亚有限公司	治疗或预防慢性创伤的方法及其中所使用的包含甘氨酸和/或亮氨酸的全营养组合物
JP4528925B2 (ja) *	2003-05-30	2010-08-25	独立行政法人理化学研究所	アミノ酸組成物及び補液
ITTO20030789A1 (it)	2003-10-07	2005-04-08	Professional Dietetics Srl	Composizione a base di amino acidi per il trattamento
WO2005110124A1 (en) *	2004-04-15	2005-11-24	Abbott Laboratories	Composition and methods for nutritional management of patients with hepatic disease
US20050271726A1 (en) *	2004-06-02	2005-12-08	Albert Crum	Immune enhancing compositions and methods of use thereof
US20070114476A1 (en) *	2005-11-04	2007-05-24	Williams Christopher P	Low radiocarbon nucleotide and amino acid dietary supplements
PL1983849T3 (pl) *	2006-01-20	2013-09-30	Innova Food Ab	Kompozycja spożywcza zawierająca aminokwasy
DE102006018293A1 (de) *	2006-04-20	2007-10-25	Fresenius Kabi Deutschland Gmbh	Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
US8722120B2 (en) *	2006-08-02	2014-05-13	Mead Johnson Nutrition Company	Amino acid-based nutritional formulations
GB0624879D0 (en) *	2006-12-14	2007-01-24	Shs Int Ltd	Treatment of pervasive development disorders
EP2158462A4 (de)	2007-05-03	2010-05-05	Radiocarb Genetics Inc	Nahrungsergänzungen mit wenig radiokohlenstoff und herstellungsverfahren dafür
JP5527986B2 (ja) *	2008-02-19	2014-06-25	株式会社アーネストメディスン	医薬組成物
KR101325374B1 (ko) *	2008-02-19	2013-11-08	가부시키가이샤 오츠까 세이야꾸 고죠	신체 기능의 회복에 유용한 경구 또는 경장 조성물
EP2143340A1 (de) *	2008-07-07	2010-01-13	Nestec S.A.	Nährstoffzusammensetzung mit freien Aminosäuren und strukturierten Lipiden
ES2534245T3 (es)	2008-11-04	2015-04-20	Vymedic, Llc	Formulaciones de suplemento antiviral
US20100210600A1 (en) *	2009-02-19	2010-08-19	Prelief Inc.	Methods and Compositions for Treating Urogenital Disorders
WO2011119023A1 (en) *	2010-03-26	2011-09-29	N.V. Nutricia	Low protein infant formula with increased essential amino acids
BR112013033127B1 (pt)	2011-06-23	2020-11-03	Innovafood Ab	suplemento alimentar, uso do suplemento alimentar, e composição alimentar
WO2015085351A1 (en) *	2013-12-12	2015-06-18	Newsouth Innovations Pty Limited	Pharmaconutrient composition
CN107105748A (zh) *	2014-09-25	2017-08-29	纽奇瑞迪专业有限公司	在青春期前的少年中用于促生长的营养补充剂
US10413528B2 (en) *	2014-10-20	2019-09-17	John H. Plumb	Methods to inhibit infection during wound healing with topical compositions including amino acids
AU2016208455A1 (en)	2015-01-23	2017-06-15	Société des Produits Nestlé S.A.	Nutritional composition useful in the treatment of IBD patients
BR112017026185A2 (pt) *	2015-06-10	2018-08-14	Ajinomoto Kk	agente e método para melhorar um distúrbio gastrointestinal induzido por exercício.
JOP20190146A1 (ar)	2016-12-19	2019-06-18	Axcella Health Inc	تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IL296055A (en)	2017-08-14	2022-10-01	Axcella Health Inc	Amino acid compositions for the treatment of liver disease
WO2019246221A1 (en) *	2018-06-20	2019-12-26	Axcella Health Inc.	Compositions and methods for the treatment of liver diseases and disorders
MA52971A (fr)	2018-06-20	2021-04-28	Axcella Health Inc	Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
WO2020089447A2 (en)	2018-11-02	2020-05-07	Société des Produits Nestlé S.A.	Powders containing a buffer salt and an amino acid, reconstitution of such a powder into a nutritional product, and methods of using such a nutritional product
US11412771B2 (en) *	2019-04-12	2022-08-16	The Amino Company LLC	Composition to improve athletic performance by supporting muscle protein synthesis and mental focus
MX2022004217A (es) *	2019-10-10	2022-07-19	Axcella Health Inc	Formulas de volumen reducido que incluyen entidades de aminoacidos.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3701666A (en) *	1968-02-14	1972-10-31	Morton Norwich Products Inc	Process for making amino acid composition
US3697287A (en) *	1969-01-28	1972-10-10	Morton Norwich Products Inc	Amino acid food composition
US3773930A (en) *	1971-03-23	1973-11-20	Johnson & Johnson	Amino acid composition
JPS56110617A (en) *	1980-02-08	1981-09-01	Ajinomoto Co Inc	Nutrient composition for young child
SU1228844A1 (ru) *	1982-11-12	1986-05-07	Московский Городской Научно-Исследовательский Ордена Ленина И Ордена Трудового Красного Знамени Институт Скорой Помощи Им.Н.В.Склифосовского	Смесь дл энтерального зондового питани
US4871550A (en) *	1986-09-05	1989-10-03	Millman Phillip L	Nutrient composition for athletes and method of making and using the same
EP0312612B1 (de) *	1987-05-01	1993-03-24	Otsuka Pharmaceutical Co., Ltd.	Nährmittelemulsion
US5026721A (en) *	1989-06-05	1991-06-25	Dudrick Stanley J	Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition
DK0421309T4 (da) *	1989-10-02	2003-04-22	Associated British Foods Plc	Proteinhydrolysater
JPH05163160A (ja) *	1991-12-13	1993-06-29	Snow Brand Milk Prod Co Ltd	免疫低下に伴う感染症の予防及び治療用栄養剤
US5326569A (en) *	1992-12-23	1994-07-05	Abbott Laboratories	Medical foods for the nutritional support of child/adult metabolic diseases

1994
- 1994-09-21 US US08/309,815 patent/US5719133A/en not_active Expired - Lifetime
1995
- 1995-09-19 ES ES95810580T patent/ES2111384T3/es not_active Expired - Lifetime
- 1995-09-19 AT AT95810580T patent/ATE161397T1/de active
- 1995-09-19 EP EP95810580A patent/EP0705542B1/de not_active Expired - Lifetime
- 1995-09-19 SI SI9530040T patent/SI0705542T1/xx not_active IP Right Cessation
- 1995-09-19 CA CA002158635A patent/CA2158635C/en not_active Expired - Lifetime
- 1995-09-19 DE DE69501306T patent/DE69501306T2/de not_active Expired - Lifetime
- 1995-10-03 TW TW084110289A patent/TW410160B/zh not_active IP Right Cessation
1996
- 1996-09-17 US US08/715,298 patent/US5719134A/en not_active Expired - Lifetime
1998
- 1998-02-04 GR GR980400240T patent/GR3026072T3/el unknown
- 1998-06-04 HK HK98104872A patent/HK1005768A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0705542B1 (de)	1997-12-29
DE69501306D1 (de)	1998-02-05
TW410160B (en)	2000-11-01
DE69501306T2 (de)	1998-06-18
EP0705542A1 (de)	1996-04-10
ATE161397T1 (de)	1998-01-15
CA2158635C (en)	1998-05-12
ES2111384T3 (es)	1998-03-01
CA2158635A1 (en)	1996-03-22
HK1005768A1 (en)	1999-01-22
GR3026072T3 (en)	1998-05-29
US5719133A (en)	1998-02-17
US5719134A (en)	1998-02-17

Legal Events

Date

Code

Title

Description

2005-02-28

SP73

Change of data on owner

Owner name: NOVARTIS AG; CH

Effective date: 20050117

2010-01-29